Cloverleaf Bio, Inc.

New Haven, CT

UEI
NR4GYWZ66HM5
CAGE
0QEA6
Primary NAICS
541713 Research and Development in Nanotechnology
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
101 College St #210, New Haven, CT 06510, USA
Website
cloverleafbio.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Cloverleaf Bio, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir FY25 concept award: development of engineered trna therapeutics for clear cell renal cell carcinoma Contract · 75N91025C00020 National Cancer Institute $300,000
Developing engineered inhibitors of trna modifying enzymes - project summary/abstract liver cancer is a growing public… Grant · R42CA290914 National Cancer Institute $399,966

Quick answers

What is Cloverleaf Bio, Inc.'s UEI?

Cloverleaf Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is NR4GYWZ66HM5.

What is Cloverleaf Bio, Inc.'s CAGE code?

Cloverleaf Bio, Inc.'s CAGE code is 0QEA6.

What is Cloverleaf Bio, Inc.'s primary NAICS code?

Cloverleaf Bio, Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).

Where is Cloverleaf Bio, Inc. located?

Cloverleaf Bio, Inc.'s physical address in SAM.gov is 101 College St #210, New Haven, CT 06510, USA.

Is Cloverleaf Bio, Inc. registered in SAM.gov?

Yes. Cloverleaf Bio, Inc.'s SAM.gov registration is active through November 5, 2026.

What is Cloverleaf Bio, Inc.'s most recent federal award?

Cloverleaf Bio, Inc.'s most recent federal contract award is Sbir FY25 concept award: development of engineered trna therapeutics for clear cell renal cell carcinoma (75N91025C00020), from National Cancer Institute, on September 15, 2025.

On GovTribe

See Cloverleaf Bio, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login